首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 段丽萍
2024
CA
Antibiotic exposure and risk of new-onset inflammatory bowel disease: a systematic review and dose-response meta-analysis
CLIN GASTROENTEROL H, 10.1016/j.cgh.2024.02.010
CA
Genetic associations and potential mediators between psychiatric disorders and irritable bowel syndrome: a Mendelian randomization study with mediation analysis
FRONT PSYCHIATRY, 10.3389/fpsyt.2024.1279266
2023
CA
Distinct Effects of Non-absorbed Agents Rifaximin and Berberine on the Microbiota-Gut-Brain Axis in Dysbiosis-induced Visceral Hypersensitivity in Rats
JNM, 10.5056/jnm22182
CA
"Sentinel or accomplice" - gut microbiota and microglia cross-talk in disorders of gut-brain interaction
PROTEIN CELL, 10.1093/procel/pwad020
点击查看热心肠日报解读
CA
The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review
Nutrients, 10.3390/nu15071566
CA
Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)
FPHAR, 10.3389/fphar.2023.1121435
2022
CA
The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases
Pharmacol Res, 10.1016/j.phrs.2022.106530
CA
Clinical Characteristics of Patients With Chronic Pancreatitis With or Without Prior Acute Pancreatitis Are Different
PANCREAS, 10.1097/MPA.0000000000002142
CA
Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity
Chin Med J, 10.1097/CM9.0000000000002294
点击查看热心肠日报解读
CA
Roseburia hominis Alleviates Neuroinflammation via Short-Chain Fatty Acids through Histone Deacetylase Inhibition
MOL NUTR FOOD RES, 10.1002/mnfr.202200164
点击查看热心肠日报解读
CA
Berberine Suppresses Lung Metastasis of Cancer via Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1
FPHAR, 10.3389/fphar.2022.917827
CA
Berberine Suppresses Lung Metastasis of Cancer via Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1
FPHAR, 10.3389/fphar.2022.917827
CA
Berberine Suppresses Lung Metastasis of Cancer Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1
FPHAR, 10.3389/fphar.2022.917827
CA
Features of Gut Microbiome Associated With Responses to Fecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review
FRONT MED-LAUSANNE, 10.3389/fmed.2022.773105
CA
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
FCIMB, 10.3389/fcimb.2022.859967
CA
Early identification of high-risk patients with recurrent acute pancreatitis progression to chronic pancreatitis
AMS, 10.5114/aoms/146262
2021
CA
Identification of an orally active carbazole aminoalcohol derivative with broad-spectrum anti-animal trypanosomiasis activity
ACTA TROP, 10.1016/j.actatropica.2021.105919
CA
Association between short-term exposure to fine particulate pollution and outpatient visits for ulcerative colitis in Beijing, China: A time-series study
EES, 10.1016/j.ecoenv.2021.112116
CA
Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis
GENOM PROTEOM BIOINF, 10.1016/j.gpb.2020.06.013
点击查看热心肠日报解读
CA
The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients
J GASTROEN HEPATOL, 10.1111/jgh.15432